EUVIMED · CrossrefZeitschrift
Preventive Cardiology
ISSN 1520-037X · Wiley
Neueste Artikel
Effect of Obesity on Platelet Reactivity and Response to Low-Dose Aspirin
Postprandial Metabolic Responses to Dietary Glycemic Index in Hypercholesterolemic Postmenopausal Women
Association of SF-36 With Coronary Artery Disease Risk Factors and Mortality: A PreCIS Study
Distribution and Predictors of Carotid Intima‐Media Thickness in Young Adults
Ethnic Differences in Barriers and Referral to Cardiac Rehabilitation Among Women Hospitalized With Coronary Heart Disease
Trait Anger and Arterial Stiffness: Results From the Atherosclerosis Risk in Communities (ARIC) Study
Controlled Endurance Exercise Training and VO 2max Changes in Older Adults: A Meta‐Analysis
Reducing the Global Burden of Cardiovascular Disease: The Role of Risk Factors
Resolving the Coronary Artery Disease Epidemic Through Plant‐Based Nutrition
Effects of Hatha Yoga Practice on the Health‐Related Aspects of Physical Fitness
Exercise, Lipids, and Lipoproteins in Older Adults: A Meta‐Analysis
Participation in an Older Adult Heart Health Program Affects Lifestyle Behavior
Substudies of ALLHAT and Heart Protection Study
Revised American College of Cardiology/American Heart Association Guidelines for the Management of Heart Failure
Evaluation of Asymptomatic Patients With High Risk Profiles: Which Test for Which Patient?
Considerations in the Treatment of Dyslipidemia Associated With Chronic Kidney Failure and Renal Transplantation
Time as a Variable With Niacin Extended‐Release/Lovastatin vs. Atorvastatin and Simvastatin
Decreasing LDL Cholesterol and Medication Cost With Every‐Other‐Day Statin Therapy
Obesity—A Critical Issue in Preventive Cardiology: The Bogalusa Heart Study
AMERICAN SOCIETY FOR PREVENTIVE CARDIOLOGY
LETTER TO THE EDITOR
Depressive Symptoms and Sex Affect Completion Rates and Clinical Outcomes in Cardiac Rehabilitation
Lipid Management Reduces Cardiovascular Complications in Individuals With Diabetes and Prediabetes
Rationale for Intensive Statin Treatment in High‐Risk Patients
Muraglitazar and the FDA: What Constitutes Drug Safety?
AHA Prevention V: Broadening the Concept of Primary Prevention
High Density Lipoprotein and Coronary Heart Disease: Lessons From Recent Intervention Trials
Hormone Replacement Therapy (Estrogen and Progesterone): Is it Necessary for Heart Disease Prevention?
Herbs and Dietary Supplements in the Prevention and Treatment of Cardiovascular Disease
Lipid Lowering Strategies in Women
EUVIMED